CIBC Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26M | Sell |
41,660
-857
| -2% | -$583K | 0.06% | 226 |
|
|
2026
Q1 | $32.9M | Sell |
42,517
-150
| -0.4% | -$115K | 0.08% | 179 |
|
|
2025
Q4 | $32.9M | Buy |
42,667
+10,329
| +32% | +$7.01M | 0.08% | 175 |
|
|
2025
Q3 | $18.2M | Sell |
32,338
-585
| -2% | -$331K | 0.05% | 222 |
|
|
2025
Q2 | $17.3M | Sell |
32,923
-1,573
| -5% | -$878K | 0.05% | 224 |
|
|
2025
Q1 | $21.9M | Buy |
34,496
+110
| +0.3% | +$75.7K | 0.07% | 183 |
|
|
2024
Q4 | $24.5M | Buy |
34,386
+1,034
| +3% | +$868K | 0.08% | 163 |
|
|
2024
Q3 | $35.1M | Buy |
33,352
+1,843
| +6% | +$2.05M | 0.11% | 128 |
|
|
2024
Q2 | $33.1M | Buy |
31,509
+4
| +0% | +$3.88K | 0.12% | 123 |
|
|
2024
Q1 | $30.3M | Buy |
31,505
+1,692
| +6% | +$1.61M | 0.11% | 133 |
|
|
2023
Q4 | $26.2M | Buy |
29,813
+142
| +0.5% | +$117K | 0.1% | 145 |
|
|
2023
Q3 | $24.4M | Buy |
29,671
+2,809
| +10% | +$2.21M | 0.1% | 139 |
|
|
2023
Q2 | $19.3M | Sell |
26,862
-148
| -0.5% | -$114K | 0.07% | 166 |
|
|
2023
Q1 | $22.2M | Buy |
27,010
+336
| +1% | +$253K | 0.09% | 152 |
|
|
2022
Q4 | $19.2M | Sell |
26,674
-11
| -0% | -$8.12K | 0.08% | 155 |
|
|
2022
Q3 | $18.4M | Buy |
26,685
+1,611
| +6% | +$1.01M | 0.08% | 154 |
|
|
2022
Q2 | $14.8M | Sell |
25,074
-256
| -1% | -$166K | 0.06% | 171 |
|
|
2022
Q1 | $17.7M | Sell |
25,330
-747
| -3% | -$473K | 0.06% | 170 |
|
|
2021
Q4 | $16.5M | Buy |
26,077
+2,046
| +9% | +$1.26M | 0.06% | 177 |
|
|
2021
Q3 | $14.5M | Buy |
24,031
+156
| +0.7% | +$96.8K | 0.06% | 189 |
|
|
2021
Q2 | $13.3M | Buy |
23,875
+1,292
| +6% | +$655K | 0.05% | 196 |
|
|
2021
Q1 | $10.7M | Buy |
22,583
+3,049
| +16% | +$1.48M | 0.05% | 214 |
|
|
2020
Q4 | $9.44M | Buy |
19,534
+1,277
| +7% | +$689K | 0.04% | 218 |
|
|
2020
Q3 | $10.2M | Buy |
18,257
+2,892
| +19% | +$1.75M | 0.05% | 190 |
|
|
2020
Q2 | $9.58M | Buy |
15,365
+1,054
| +7% | +$598K | 0.06% | 186 |
|
|
2020
Q1 | $6.99M | Buy |
14,311
+24
| +0.2% | +$9.9K | 0.05% | 205 |
|
|
2019
Q4 | $5.36M | Buy |
14,287
+737
| +5% | +$248K | 0.03% | 249 |
|
|
2019
Q3 | $3.76M | Sell |
13,550
-164
| -1% | -$48.5K | 0.02% | 301 |
|
|
2019
Q2 | $4.29M | Buy |
13,714
+369
| +3% | +$123K | 0.03% | 272 |
|
|
2019
Q1 | $5.48M | Sell |
13,345
-83
| -0.6% | -$34.2K | 0.03% | 221 |
|
|
2018
Q4 | $5.01M | Buy |
13,428
+272
| +2% | +$99.6K | 0.04% | 193 |
|
|
2018
Q3 | $5.32M | Buy |
13,156
+266
| +2% | +$101K | 0.03% | 207 |
|
|
2018
Q2 | $4.45M | Buy |
12,890
+605
| +5% | +$189K | 0.03% | 234 |
|
|
2018
Q1 | $4.23M | Sell |
12,285
-33
| -0.3% | -$11.5K | 0.03% | 236 |
|
|
2017
Q4 | $4.63M | Buy |
12,318
+634
| +5% | +$257K | 0.03% | 237 |
|
|
2017
Q3 | $5.22M | Buy |
11,684
+264
| +2% | +$126K | 0.03% | 213 |
|
|
2017
Q2 | $5.61M | Buy |
11,420
+422
| +4% | +$185K | 0.04% | 188 |
|
|
2017
Q1 | $4.26M | Buy |
10,998
+293
| +3% | +$109K | 0.03% | 235 |
|
|
2016
Q4 | $3.93M | Sell |
10,705
-78
| -0.7% | -$29.7K | 0.03% | 242 |
|
|
2016
Q3 | $4.33M | Sell |
10,783
-605
| -5% | -$243K | 0.03% | 229 |
|
|
2016
Q2 | $3.98M | Buy |
11,388
+175
| +2% | +$67.4K | 0.03% | 232 |
|
|
2016
Q1 | $4.04M | Buy |
11,213
+302
| +3% | +$124K | 0.03% | 226 |
|
|
2015
Q4 | $5.92M | Sell |
10,911
-394
| -3% | -$213K | 0.05% | 161 |
|
|
2015
Q3 | $5.26M | Buy |
11,305
+122
| +1% | +$65.5K | 0.04% | 170 |
|
|
2015
Q2 | $5.71M | Buy |
11,183
+276
| +3% | +$135K | 0.04% | 181 |
|
|
2015
Q1 | $4.92M | Buy |
10,907
+568
| +5% | +$241K | 0.03% | 197 |
|
|
2014
Q4 | $4.24M | Sell |
10,339
-2,352
| -19% | -$925K | 0.03% | 209 |
|
|
2014
Q3 | $4.58M | Sell |
12,691
-207
| -2% | -$69.4K | 0.03% | 224 |
|
|
2014
Q2 | $3.64M | Sell |
12,898
-414
| -3% | -$123K | 0.02% | 272 |
|
|
2014
Q1 | $4M | Buy |
13,312
+547
| +4% | +$169K | 0.02% | 254 |
|
|
2013
Q4 | $3.51M | Buy |
12,765
+81
| +0.6% | +$23.3K | 0.02% | 264 |
|
|
2013
Q3 | $3.97M | Buy |
12,684
+107
| +0.9% | +$28.1K | 0.03% | 241 |
|
|
2013
Q2 | $2.83M | Buy |
+12,577
| New | +$2.93M | 0.02% | 282 |
|
Other funds holding REGN
CIBC Asset Management's REGN Position: Q2 2026 in Review
CIBC Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 2% in Q2 2026, selling an estimated $583K and leaving 41,660 shares worth $26M. The position accounts for 0.06% of the portfolio, ranked #226.
CIBC Asset Management first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $35.1M in Q3 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- CIBC Asset Management held 41,660 shares of Regeneron Pharmaceuticals worth $26M as of Q2 2026.
- CIBC Asset Management sold 857 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $583K.
- Regeneron Pharmaceuticals made up 0.06% of CIBC Asset Management's portfolio in Q2 2026, its #226 holding.
- CIBC Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- CIBC Asset Management's Regeneron Pharmaceuticals position peaked at $35.1M in Q3 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.